Vaccine Therapy in Non-Small Cell Lung Cancer
Miguel García-Pardo(Hospital Universitario Ramón y Cajal), Laura Mezquita(Hospital Clínic de Barcelona), Cristina Teixidó(Hospital Clínic de Barcelona), Ines Malenica(IRCCS Humanitas Research Hospital), Stéphanie Corgnac(Inserm), Teresa Gorría(Hospital Clínic de Barcelona)
Cited by 23
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
The Emerging Role of CD8+ Tissue Resident Memory T (TRM) Cells in Antitumor Immunity: A Unique Functional Contribution of the CD103 Integrin
|Frontiers in Immunology|2018|161
Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges
|British Journal of Cancer|2022|112
Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer
|JAMA Network Open|2023|60
Geographic differences in lung cancer: focus on carcinogens, genetic predisposition, and molecular epidemiology
|Therapeutic Advances in Medical Oncology|2024|48